Serum Sphingosine-1-Phosphate Is Decreased in Patients With Acute-on-Chronic Liver Failure and Predicts Early Mortality.


Journal

Hepatology communications
ISSN: 2471-254X
Titre abrégé: Hepatol Commun
Pays: United States
ID NLM: 101695860

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 13 04 2020
revised: 17 05 2020
accepted: 10 06 2020
entrez: 7 10 2020
pubmed: 8 10 2020
medline: 8 10 2020
Statut: epublish

Résumé

Sphingosine-1-phosphate (S1P) regulates pathophysiological processes, including liver regeneration, vascular tone control, and immune response. In patients with liver cirrhosis, acute deterioration of liver function is associated with high mortality rates. The present study investigated whether serum S1P concentrations are associated with disease severity in patients with chronic liver disease from compensated cirrhosis (CC), acute decompensation (AD), or acute-on-chronic liver failure (ACLF). From August 2013 to October 2017, patients who were admitted to the University Hospital Frankfurt with CC, AD, or ACLF were enrolled in our cirrhosis cohort study. Tandem mass spectrometry was performed on serum samples of 127 patients to assess S1P concentration. Our study comprised 19 patients with CC, 55 with AD, and 51 with ACLF, aged 29 to 76 years. We observed a significant decrease of S1P according to advanced liver injury from CC and AD up to ACLF (

Identifiants

pubmed: 33024917
doi: 10.1002/hep4.1561
pii: HEP41561
pmc: PMC7527696
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1477-1486

Informations de copyright

© 2020 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.

Références

Curr Top Microbiol Immunol. 2014;378:85-105
pubmed: 24728594
Am J Transplant. 2004 Jul;4(7):1019-25
pubmed: 15196057
Crit Rev Biochem Mol Biol. 2017 Oct;52(5):543-553
pubmed: 28618839
Liver Int. 2017 Feb;37(2):232-241
pubmed: 27473364
Prostaglandins Other Lipid Mediat. 2013 Oct;106:62-71
pubmed: 23770055
PLoS One. 2018 Nov 15;13(11):e0207293
pubmed: 30439997
J Lipid Res. 2014 Aug;55(8):1596-608
pubmed: 24459205
J Cell Biochem. 2004 Aug 15;92(6):1075-85
pubmed: 15258893
Gastroenterology. 2015 Mar;148(3):603-615.e14
pubmed: 25479139
Biochim Biophys Acta. 2000 May 31;1485(2-3):63-99
pubmed: 10832090
Liver Int. 2018 Apr;38(4):645-653
pubmed: 28853199
Sci Rep. 2016 Aug 31;6:32341
pubmed: 27578545
Gastroenterology. 2013 Jun;144(7):1426-37, 1437.e1-9
pubmed: 23474284
Pharmacol Ther. 2018 May;185:34-49
pubmed: 29127024
Nature. 2014 Jun 5;510(7503):58-67
pubmed: 24899305
Hepatology. 2007 Mar;45(3):797-805
pubmed: 17326206
Liver Int. 2018 May;38(5):875-884
pubmed: 29105936
Medicine (Baltimore). 2016 Apr;95(16):e3405
pubmed: 27100428
Gut. 2017 Mar;66(3):541-553
pubmed: 28053053
Curr Opin Lipidol. 2008 Oct;19(5):543-4
pubmed: 18769238
Biol Chem. 2015 Jun;396(6-7):633-43
pubmed: 25781682
Oncotarget. 2016 Apr 5;7(14):18095-105
pubmed: 26933996
Hepatology. 2015 Jul;62(1):243-52
pubmed: 25877702
Liver Int. 2019 Nov;39(11):2174-2183
pubmed: 31207039
Sci Rep. 2016 Aug 01;6:30655
pubmed: 27476912
PLoS One. 2017 Mar 23;12(3):e0174424
pubmed: 28334008
Circ Res. 2006 Sep 29;99(7):731-9
pubmed: 16960101
Int J Mol Sci. 2018 Mar 26;19(4):
pubmed: 29587453
Cochrane Database Syst Rev. 2016 Apr 19;4:CD009371
pubmed: 27091121
Circ Res. 2008 Mar 28;102(6):669-76
pubmed: 18258856
J Cell Biochem. 2014 Jun;115(6):1187-95
pubmed: 24851274
Int J Mol Sci. 2016 Jun 13;17(6):
pubmed: 27304952
Cell Mol Immunol. 2006 Feb;3(1):11-9
pubmed: 16549044
J Biol Chem. 2005 Jul 29;280(30):27879-87
pubmed: 15946935
Hepatol Res. 2015 Nov;45(11):1136-45
pubmed: 25371278
Hepatology. 2016 Oct;64(4):1249-64
pubmed: 27483394
Placenta. 2014 Feb;35 Suppl:S86-92
pubmed: 24411702
J Immunol. 2001 Jul 1;167(1):173-80
pubmed: 11418646
Int J Mol Sci. 2017 Jul 27;18(8):
pubmed: 28749426
Hepatol Commun. 2019 Jan 17;3(3):392-405
pubmed: 30859151
Crit Care. 2015 Oct 26;19:372
pubmed: 26498205
Mediators Inflamm. 2015;2015:831059
pubmed: 26604433
Semin Liver Dis. 2016 May;36(2):133-40
pubmed: 27172355
Shock. 2016 Mar;45(3):259-70
pubmed: 26871664
Am J Transplant. 2005 Jan;5(1):40-9
pubmed: 15636610
J Hepatol. 2016 Jan;64(1):60-8
pubmed: 26254847
Annu Rev Immunol. 2012;30:69-94
pubmed: 22149932

Auteurs

Victoria T Mücke (VT)

Departement of Internal Medicine 1 University Hospital Frankfurt Goethe University Frankfurt am Main Germany.

Katharina Maria Schwarzkopf (K)

Departement of Internal Medicine 1 University Hospital Frankfurt Goethe University Frankfurt am Main Germany.

Dominique Thomas (D)

Pharmazentrum Frankfurt Institute of Clinical Pharmacology Goethe University Frankfurt am Main Germany.

Marcus M Mücke (MM)

Departement of Internal Medicine 1 University Hospital Frankfurt Goethe University Frankfurt am Main Germany.

Sabrina Rüschenbaum (S)

Department of Gastroenterology and Hepatology University Hospital Essen University of Duisburg-Essen Essen Germany.

Jonel Trebicka (J)

Departement of Internal Medicine 1 University Hospital Frankfurt Goethe University Frankfurt am Main Germany.

Josef Pfeilschifter (J)

Pharmazentrum Frankfurt Institute of General Pharmacology and Toxicology Goethe University Frankfurt am Main Germany.

Stefan Zeuzem (S)

Departement of Internal Medicine 1 University Hospital Frankfurt Goethe University Frankfurt am Main Germany.

Christian M Lange (CM)

Department of Gastroenterology and Hepatology University Hospital Essen University of Duisburg-Essen Essen Germany.

Georgios Grammatikos (G)

Departement of Internal Medicine 1 University Hospital Frankfurt Goethe University Frankfurt am Main Germany.
St. Luke's Hospital Thessaloniki Panorama Greece.

Classifications MeSH